journal article·2025-05-28

Polymer-Based Raman/PET Dual-Modal Probe for Preoperative Tumor Diagnosis and Intraoperative Image-Guided Surgery and Phototherapy

Yuanyuan Qiu, Qi Zhu, Kai Cui, Haoze Wang, Wenxian Zhang, Xinyi Li, Jiapei Yu, Yumeng Li, Yating Luo, Yiyuan Wang, Wenhui Xie, Qian Xia, Zeyu Xiao

ACS Applied Materials & Interfaces· Volume 17· Issue 21
Publisher page

Abstract

Integration of Raman imaging and positron emission tomography (PET) holds great promise for providing complementary information for precise cancer diagnosis and imaging-guided therapy. However, current existing Raman/PET dual-modal probes primarily rely on surface-enhanced Raman scattering, raising clinical concerns about the biosafety of the substrates. Herein, we developed a novel substrate-free Raman/PET probe-[ 18 F]-AS-DPPT-TT NPs, which integrates a biocompatible polymer DPPT-TT that possesses strong Raman signals and photothermal effects, along with radiolabeling by short-lived 18 F radionuclide and functionalization with tumor-targeting AS1411 aptamer. The [ 18 F]-AS-DPPT-TT NPs generate ultrasensitive resonance Raman signals under 785 nm excitation, due to their absorption peak closely matching the excitation light, and exhibit significant photothermal effects for tumor cell ablation under 808 nm excitation. In the orthotopic colon cancer mouse models, [ 18 F]-AS-DPPT-TT NPs enabled preoperative PET imaging for high-contrast whole-body tumor localization and simultaneously provided intraoperative Raman imaging for accurate tumor boundary delineation and micrometastasis detection (as small as 0.58 mm × 0.32 mm). Moreover, Raman imaging-guided surgery combined with photothermal therapy achieved complete elimination of primary and metastatic tumors, significantly decreasing the recurrence rates. This Raman/PET dual-modal probe effectively combines the strengths of Raman and PET imaging, providing a robust platform for comprehensive tumor management from preoperative planning to intraoperative intervention.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacology and Chemical Biology, Institute of Molecular Medicine, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education

Shanghai Jiao Tong University School of Medicine

Institute of Molecular Medicine and Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, State Key Laboratory of Oncogenes and Related Genes,Department of Nuclear Medicine, Renji Hospital

Hangzhou Institute of Medicine (HIM)

Chinese Academy of Sciences

Department of Nuclear Medicine, Shanghai Chest Hospital, School of Medicine

Shanghai Jiao Tong University

Funding

Shanghai Jiao Tong University · National Key Research and Development Program of China · School of Medicine, Shanghai Jiao Tong University · Science and Technology Commission of Shanghai Municipality · Fundamental Research Funds for the Central Universities · Shanghai Municipal Health Commission · National Natural Science Foundation of China

References (50)

Show source-provided references
1. 10.1002/adfm.20220608410.1002/adfm.202206084 ↗
2. 10.7150/thno.1801910.7150/thno.18019 ↗
3. 10.1002/bmm2.1203210.1002/bmm2.12032 ↗
4. 10.1038/s41467-019-10056-910.1038/s41467-019-10056-9 ↗
5. 10.1016/j.addr.2022.11444710.1016/j.addr.2022.114447 ↗
6. 10.1038/s41467-024-53135-210.1038/s41467-024-53135-2 ↗
7. 10.1021/acsami.2c0254010.1021/acsami.2c02540 ↗
8. 10.1039/C9CS00326F10.1039/C9CS00326F ↗
9. 10.1002/advs.20220205110.1002/advs.202202051 ↗
10. 10.1021/acsami.4c1750210.1021/acsami.4c17502 ↗
11. 10.1021/jacs.4c1641110.1021/jacs.4c16411 ↗
12. 10.1016/j.chempr.2019.07.01510.1016/j.chempr.2019.07.015 ↗
13. 10.1021/acs.chemrev.7b0066810.1021/acs.chemrev.7b00668 ↗
14. 10.1021/acsnano.2c1037810.1021/acsnano.2c10378 ↗
15. 10.1126/science.275.5303.110210.1126/science.275.5303.1102 ↗
16. 10.1002/adfm.20220802810.1002/adfm.202208028 ↗
17. 10.1002/smll.20210692510.1002/smll.202106925 ↗
18. 10.1002/smll.20240223510.1002/smll.202402235 ↗
19. 10.1002/anie.20180685310.1002/anie.201806853 ↗
20. 10.1371/journal.pmed.002007010.1371/journal.pmed.0020070 ↗
21. 10.1021/acs.molpharmaceut.3c0066010.1021/acs.molpharmaceut.3c00660 ↗
22. 10.1002/anie.20220036910.1002/anie.202200369 ↗
23. 10.1002/smll.20210037810.1002/smll.202100378 ↗
24. 10.1021/cr300120g10.1021/cr300120g ↗
25. 10.1021/acs.analchem.4c0137610.1021/acs.analchem.4c01376 ↗
26. 10.1021/acs.analchem.4c0381710.1021/acs.analchem.4c03817 ↗
27. 10.1021/acs.nanolett.2c0341610.1021/acs.nanolett.2c03416 ↗
28. 10.1073/pnas.070765410510.1073/pnas.0707654105 ↗
29. 10.1126/science.280.5370.174110.1126/science.280.5370.1741 ↗
30. 10.1002/anie.20200927210.1002/anie.202009272 ↗
31. 10.1002/anie.20221297910.1002/anie.202212979 ↗
32. 10.1002/adfm.20190393610.1002/adfm.201903936 ↗
33. 10.1039/C9BM00997C10.1039/C9BM00997C ↗
34. 10.1021/acsami.3c0700810.1021/acsami.3c07008 ↗
35. 10.1021/acs.accounts.7b0062410.1021/acs.accounts.7b00624 ↗
36. 10.1039/D2MH01520J10.1039/D2MH01520J ↗
37. 10.1021/acsami.1c0364310.1021/acsami.1c03643 ↗
38. 10.1021/ja204515s10.1021/ja204515s ↗
39. 10.1002/adfm.20210295310.1002/adfm.202102953 ↗
40. 10.1021/acsami.1c2404810.1021/acsami.1c24048 ↗
41. 10.1021/acs.nanolett.4c0549710.1021/acs.nanolett.4c05497 ↗
42. 10.1016/j.fmre.2022.06.00110.1016/j.fmre.2022.06.001 ↗
43. 10.1021/acsami.3c1814010.1021/acsami.3c18140 ↗
44. 10.1021/acsnano.1c0526510.1021/acsnano.1c05265 ↗
45. 10.1021/acsnano.8b0268110.1021/acsnano.8b02681 ↗
46. 10.1055/s-0043-12044110.1055/s-0043-120441 ↗
47. 10.1021/acsami.3c0469610.1021/acsami.3c04696 ↗
48. 10.1021/acs.chemmater.6b0373810.1021/acs.chemmater.6b03738 ↗
49. 10.7150/thno.9902510.7150/thno.99025 ↗
50. 10.1038/s41587-024-02342-910.1038/s41587-024-02342-9 ↗